Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Francisco
Marín Ortuño
Publicacións nas que colabora con Francisco Marín Ortuño (39)
2024
-
Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: The PANDORA study
REC: CardioClinics, Vol. 59, Núm. 4, pp. 266-277
2023
-
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment
American Journal of Cardiology, Vol. 203, pp. 122-127
-
Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
-
Survival after Invasive or Conservative Management of Stable Coronary Disease
Circulation, Vol. 147, Núm. 1, pp. 8-19
2022
-
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry
Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465
-
Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry
Frontiers in Cardiovascular Medicine, Vol. 9
-
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184
-
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study
European Journal of Clinical Investigation
2021
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
-
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry
European Journal of Clinical Investigation, Vol. 51, Núm. 4
-
Relationship between multimorbidity and outcomes in atrial fibrillation
Experimental Gerontology, Vol. 153
2020
-
Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry
Journal of the American Heart Association, Vol. 9, Núm. 1
-
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study
Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 25, Núm. 4, pp. 316-323
-
Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study
Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 14-20
-
INR during stroke and bleeding in patients with atrial fibrillation and on vitamin K antagonists
REC: CardioClinics, Vol. 55, Núm. 3, pp. 131-138
-
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
European Journal of Internal Medicine, Vol. 78, pp. 63-68
-
La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K
REC: CardioClinics, Vol. 55, Núm. 3, pp. 131-138
-
Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice
Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 329-330
-
Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry
Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309